Skip to content

Osteoporosis is a skeletal disorder characterized by loss of bone mass, reduced bone mineral density, and deterioration of bone microarchitecture, which lead to bone fragility. Bisphosphonates that are currently approved by the FDA for the prevention or treatment (or both) of osteoporosis include alendronate, ibandronate, risedronate, and zoledronic acid. This review discusses the rationale for…

Read More

Though the incidence of stress fractures in the military is almost half of that of elite athletes (12% vs 21%), recruits who sustain stress fractures are four times more likely to be discharged from training programs and are at a higher risk for sustaining a subsequent stress fracture. Rehabilitation from stress fractures requires personnel and…

Read More

Ninety percent of patients with patellofemoral pain (PFP), a chronic musculoskeletal disorder characterized by anterior knee pain, are still in pain 4 years after the initial diagnosis. Specialists have optimized management of other chronic musculoskeletal conditions by subgrouping patients based on risk factors. While previous studies aimed to categorize patients based on imaging studies, this…

Read More